2023-509752-34-00已完成4 期
Evaluation of bioequivalence of two products containing 400 mg ibuprofen and 100 mg caffeine: Ibuprofen / Caffeine 400 mg / 100 mg coated granules (Test) vs. Thomapyrin TENSION DUO, 400mg / 100mg Filmtabletten (Reference). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers
CCDRD Cooperative Clinical Drug Research and Development AG, Hermes Pharma GmbH1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2024年8月9日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 28
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Project Manager
Scientific
CCDRD Cooperative Clinical Drug Research and Development AG
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Evaluation of bioequivalence of two products containing 50 mg dimenhydrinate: Dimenhydrinate 50 mg (Test) vs. Vomex A 50 mg Lösung zum Einnehmen im Beutel (Comparator). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers2024-515170-27-00CCDRD Cooperative Clinical Drug Research and Development AG, Hermes Pharma GmbH36
进行中（未招募）
1 期
Evaluation of bioequivalence of two products containing 400 mg ibuprofen and 100 mg caffeine: Ibuprofen / Caffeine 400 mg / 100 mg coated granules (Test) vs. Thomapyrin TENSION DUO, 400mg / 100mg Filmtabletten (Reference). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteersCTIS2023-509752-34-00CCDRD Cooperative Clinical Drug Research and Development AG28
招募中
4 期
Evaluation of the bioequivalence of two products containing esomeprazole under fed conditions: Esomeprazole-Syrup 40 mg dose (Test) vs. Nexium 40 mg (Comparator). An open, randomized, single dose, four-period, replicate, crossover trial in healthy volunteers2024-512674-97-00CCDRD Cooperative Clinical Drug Research and Development AG, BePharBel Manufacturing54
招募中
4 期
Evaluation of the bioequivalence of two products containing esomeprazole under fasting conditions: Esomeprazole-Syrup 40 mg dose (Test) vs. Nexium 40 mg (Comparator). An open, randomized, single dose, four-period, replicate, crossover trial in healthy volunteers2024-512401-89-00CCDRD Cooperative Clinical Drug Research and Development AG, BePharBel Manufacturing54
已完成
不适用
Bioequivalence study of foodot applicableJPRN-UMIN000029771SUNTORY MONOZUKURI EXPERT LIMITED24